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What is already known about this subject 
• Newly-graduated doctors prescribe medicines frequently and write a large proportion of 
prescriptions in UK hospitals but recent studies suggest that around one in ten of their 
prescriptions may contain errors 
• The ability to prescribe safely and effectively is one of the competencies identified as a key 
outcome of undergraduate medical education by the General Medical Council (the UK medical 
regulator) 
• There has been significant variation in the assessments used by medical schools to ensure that 
medical students have attained the necessary competence prior to graduation  
• Prescribing is a complex skill to assess because of the number of prescribing scenarios that might 
be tested, the variety of documentation used and the challenge of marking large numbers of 
prescriptions in a standardised way 
 
What this study adds 
• The Prescribing Safety Assessment (PSA) has been developed as a 2-hour online assessment of 
competence in relation to prescribing and supervising the use of medicines in a modern 
healthcare setting 
• The PSA delivers a standard national prescribing assessment involving around two hundred 
assessment events at academic centres around the UK (and overseas) each year and enables 
large numbers of prescriptions (around 60,000) to be instantaneously assessed against a 
standardised marking scheme 
• There was significant variation in the performance of cohorts of students from different medical 
schools  
• The vast majority of UK final-year medical students were able to meet the pre-specified standard 
of competence as defined by the PSA pass mark 
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Summary 
Aim(s). Newly graduated doctors write a large proportion of prescriptions in UK hospitals but recent 
studies have shown that they frequently make prescribing errors. The Prescribing Safety Assessment 
(PSA) has been developed as an assessment of competence in relation to prescribing and supervising 
the use of medicines. This report describes the delivery of the PSA to all UK final-year medical 
students in 2016 (PSA2016).  
Methods. The PSA is a 2-hour online assessment comprising eight sections which cover various 
aspects of prescribing defined within the outcomes of undergraduate education identified by the UK 
General Medical Council. Students sat one of four PSA ‘papers’ which had been standard-set using a 
modified Angoff process. 
Results. A total of 7,343 final-year medical students in all 31 UK medical schools sat the PSA. The 
overall pass rate was 95% with the pass rates for the individual papers ranging from 93 to 97%. The 
PSA was re-sat by 261 students who had failed and 80% of those candidates passed. The internal 
consistency (Cronbach’s alpha) of the four papers ranged from 0.74 to 0.77 (standard error of 
measurement 4.13 to 4.24%). There was a statistically significant variation in performance between 
medical school cohorts (F=32.6, p<0.001) and a strongly positive correlation in performance for 
individual schools between PSA2015 and PSA2016 (r=0.79, 95% CI 0.61 to 0.90; p<0.01). 
Conclusions. PSA2016 demonstrated the feasibility of delivering a standardised national prescribing 
assessment online. The vast majority of UK final-year medical students were able to meet a pre-
specified standard of prescribing competence. 
 
248 words (maximum 250) 
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Introduction 
Prescribing medicines is a core activity for the UK National Health Service (NHS), both in hospitals 
and primary care. Around 1 billion prescriptions are written annually in primary care in England, 
equating to an average of 20 for every member of the population [1]. Prescribing is a challenging 
task for any healthcare professional. Prescribers have to select the correct medicine, dosage, route, 
and frequency of administration, sometimes in the face of diagnostic uncertainty, taking into 
account potential individual variability in pharmacokinetics and response as a consequence of co-
morbidity, genetics, and interacting drugs [2]. Given that individual patients have different ideas and 
expectations, and the outcome of any prescription is uncertain, the prescriber also needs to be able 
to counsel the patient and plan an appropriate strategy for monitoring and follow-up for evidence of 
benefit and/or harms. It is also important that prescribers can communicate effectively with each 
other (e.g. to reconcile medication at transitions of care) and with those who dispense and 
administer medicines. 
 
With these complexities, it is perhaps not surprising that poor prescribing is common. Recent studies 
found an error rate of 7–10% amongst prescriptions written by doctors in their first year of clinical 
practice while senior doctors, both in hospital and general practice, have a prescribing error rate of 
around 5% [3–5]. Several factors continuously add to the demands made on all prescribers including 
increased age and frailty of patients, the growing complexity of treatment regimens, and an 
increasingly pressurised healthcare system.  
 
In these circumstances it is important that undergraduate medical education provides the training to 
ensure that new graduates meet minimum standards of prescribing competency. However, recent 
studies show that medical students and recent graduates often feel underprepared for and anxious 
about prescribing [6–9], a concern echoed by their supervisors [10,11] and the regulatory bodies 
[12]. Reliable evidence about prescribing competence is hard to find because relevant assessments 
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have varied significantly between medical schools and none have been widely applied or validated 
[13]. 
 
In response to these concerns, the British Pharmacological Society (BPS) and Medical Schools Council 
Assessment (MSCA) developed the Prescribing Safety Assessment (PSA) as a summative assessment 
of knowledge, judgement and skills related to prescribing and supervising the use of medicines in a 
modern healthcare system [14]. The PSA is intended to enable final-year medical students at the end 
of their undergraduate training to demonstrate that they have achieved the necessary competence 
to prescribe, and supervise the use of, medicines at the standard expected of a Foundation doctor 
(first- and second-year after graduating from medical school) in the NHS. The PSA is based on the 
competencies identified by the UK General Medical Council in Outcomes for Graduates (2015) 
(originally published in Tomorrow’s Doctors (2009)) [15]. It is delivered online and is intended to 
assess, as far as possible within the confines of a virtual environment, complex skills including 
powers of deduction and problem solving that are relevant to the work of Foundation doctors. 
 
This report describes the process and outcomes of the PSA in 2016 (PSA2016) including the 
development of the assessment papers, the delivery of the PSA, the performance of the candidates 
and medical schools, and the basic psychometric properties of the assessment.  
 
 
 
Methods 
 
Candidates 
Final-year medical students from all 31 UK medical schools were registered to take the assessment. 
The PSA was originally piloted in 2012 and 2013, before being fully implemented in all schools in 
2014 (PSA2014). Prior to 2016, a majority of medical schools hosted the PSA as a low-stakes 
formative assessment. For the first time in 2016, the postgraduate training committee representing 
  
This article is protected by copyright. All rights reserved. 
the four UK countries stipulated that all new doctors entering postgraduate (Foundation) training, 
either from UK medical schools or overseas, would be required to take the PSA (those who failed 
would be expected to participate in enhanced supervision and remediation, and would be required 
to pass the PSA before the end of their first year of training). A further 828 students from seven 
international medical schools also participated in PSA2016 but they are not considered in this report. 
 
PSA structure 
The PSA comprises eight sections, each containing a specific item style reflecting different aspects of 
the process of prescribing, reviewing and advising about medicines: prescribing (PWS), prescription 
review (REV), planning management (MAN), providing information about medicines (COM), 
calculation skills (CAL), adverse drug reactions (ADR), drug monitoring (TDM) and data interpretation 
(DAT) (Figure 1). The different sections are intended to reflect not only the process of prescribing but 
also the related skills when supervising patients prescribed medicines by others. The question items 
are based on 60 patient scenarios that offer a total of 200 marks and candidates have two hours to 
complete the assessment. The scenarios relate to one of seven clinical settings: General Internal 
Medicine (MED), General Surgery (SURG), Elderly Care (ELD), Paediatrics (PED), Psychiatry (PSY), 
Obstetrics & Gynaecology (O&G), and General Practice (GP). 
 
The detailed breakdown of marks allocated to each section is shown in Table 1. Additional rules of 
assessment construction are that each PSA ‘paper’ must have a minimum item coverage in the 
various clinical settings (MED – 8, SURG – 4, ELD – 8, PED – 4, PSY – 4, O&G – 4, GP – 8) and have 
minimum coverage of high risk drugs (at least two items on each of the following: opioid analgesics, 
anticoagulants, insulin, antimicrobials and intravenous infusion fluids). The PSA does not carry 
negative marks. 
 
 
Figure 1 here. Structure of the Prescribing Safety Assessment (PSA). 
Table 1 here. Allocation of question items and marks to each PSA section. 
 
  
This article is protected by copyright. All rights reserved. 
PSA question items and papers 
PSA question items have been developed over several years by a team of around one hundred 
trained authors (including clinical pharmacologists, other specialty and trainee doctors, general 
practitioners and pharmacists) who are mainly based in UK medical schools or NHS hospitals. Their 
question items are submitted annually and undergo a strict 5-stage quality assurance process 
overseen by the PSA Assessment Board. Items that survive each stage of review, including a national 
peer-review meeting, are entered into the PSA item bank, which now includes around 2,500 items. 
For PSA2016, items were drawn from the bank to make four 60-item papers (A, B, C and D) 
conforming to the PSA blueprint [16]. The four papers included a total of 176 unique items with 32 
classified as ‘anchor’ items which were used in three of the four papers. There were 78 items 
repeated from PSA2015. The four papers were then ratified by the Assessment Board (two-day 
meeting, November 2015), made available for standard-setting (two-day meeting, January 2016) and 
delivered to the candidates (February to June 2016).  
 
Standard-setting 
The pass marks for each paper were determined by the Standard-Setting Group comprising nine 
representatives from UK medical schools, who were selected for their knowledge of the appropriate 
minimum standard expected of Foundation year one doctors. The group used a modified Angoff 
method to derive the pass mark for each paper [17]. The meeting began with a discussion of, and 
agreement about, the attributes that would define the ‘just passing’ candidate. The group members 
then scored each item individually. To avoid ‘paper bias’, the order in which items were presented to 
group members was randomised. Those with outlying scores (‘hawks’ and ‘doves’), were asked to 
justify their scores, to inform a discussion about the item, before all members were asked to 
reconfirm or adjust their scores. The final mean scores across all group members for each item were 
used to calculate the pass mark for the paper. The derived pass marks for the four papers ranged 
from 62.0% to 65.5%. 
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Candidate preparation  
All candidates (final year medical students) were registered on the PSA online system and sent an e-
mail requesting them to activate their accounts. After activation of their accounts they had access to 
general information about the PSA, 12 information videos and four 1-hour, 30-item, practice ‘papers’ 
with question-specific feedback. Candidates were encouraged to familiarise themselves with the 
different question types and the assessment environment and to practise finding information in the 
online version of the British National Formulary (BNF) [18]. 
 
Delivery of the PSA assessment events 
The PSA online delivery system allows the PSA team to create unique events specific to a date, a 
time slot, a school, a location and a specific cohort of students thus ensuring that candidates get the 
correct paper within a secure time envelope. PSA assessment events were run on four dates 
(01.02.16, 14.03.16, 13.05.16, 01.06.16). The multiple dates enabled schools to schedule later events 
for cohorts who may have been absent on earlier days and to allow candidates who failed the 
opportunity to re-sit the PSA prior to graduation. Each PSA event was delivered live from a ‘cloud-
based’ server to each event location (a medical school computer laboratory) under invigilated 
conditions. Candidates were not allowed to use their own computers or smartphones. After logging 
into the PSA system on the day of the assessment candidates were given a unique event-specific 
password that allowed them to enter the 60-item assessment described above. Some examples of 
the assessment screens are shown in Figure 2. The prescribing items are intended to simulate the 
‘real world’ process for UK Foundation doctors who normally write prescriptions on paper (without 
electronic decision support). The medicine, dose, route and frequency of administration are each 
entered independently, selected from options provided by predictive searching of the PSA database. 
 
All candidates had access to the online BNF throughout the assessment but were not allowed to 
access other internet resources. Candidates identified by their medical schools as normally being 
entitled to an extra time allowance were given an additional 30 minutes (25%) to complete the 
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assessments and other reasonable adjustments as required by individual students were made. 
Assessment centres were provided with administrative and technical support during the events by 
staff at the MSCA office and the technical team (Rave Technologies). 
 
Figure 2 here. Example PSA question item screens: Prescribing (green), Prescription Review (blue), 
Planning Management (red), Calculation Skills (grey). 
 
 
Post-assessment review 
All prescriptions written by the candidates were scrutinised immediately after the assessment (‘post-
assessment review’) to ensure that the answer matrix for the prescribing (PWS) items took into 
account any creditworthy responses that had not been anticipated and included in the mark scheme. 
The PSA system automatically identifies all unrecognised drugs and unrecognised drug order 
sentences provided by candidates during an event. These were carefully reviewed by the PSA 
Assessment Board and appropriate scores allocated and added to the electronic marking scheme. 
Candidates’ marks were automatically updated and the additions to the answer matrix are carried 
forward to subsequent uses of the item. The post-assessment review ensures that all candidates are 
marked in a fair and consistent way across event days. The performance of other item styles was 
also reviewed at this point for any unexpected answering behaviour. The final PSA results were 
released to medical schools within two weeks of each event and to the candidates shortly 
thereafter. 
 
Feedback 
After exiting the assessment on their computers, candidates were immediately presented with a 
standard feedback form designed to explore their views about the relevance and external validity of 
the assessment, their preparedness for taking it, the quality of the online delivery system and any 
other free text comments that they might wish to provide. The medical school PSA Leads were 
provided with a standard feedback form that allowed them to describe any administrative or process 
problems that they encountered. 
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Statistical analysis 
Initial psychometric analysis was undertaken using classical test theory in both Excel and STATA v14. 
Data are presented as mean and standard deviation (SD) unless otherwise stated. For comparison 
between papers both raw and calibrated percentage scores are provided. Calibrated scores have 
been calculated using the pass mark for each paper, so that a raw score of 0% stays at 0%, a raw 
score equal to the pass mark becomes 50% and a raw score of 100% stays at 100%. Calibrated data 
were assumed to be sufficiently normally distributed to enable parametric statistical testing to be 
undertaken. One-way ANOVA was used to assess the significance of the variation between medical 
schools. Pearson rank correlation was used to measure the association between mean medical 
school performance in 2016 and 2015. Internal consistency of the papers was assessed using 
Cronbach’s alpha [19]. Standard error of measurement (SEM) was calculated using Cronbach’s alpha 
and the standard deviation of raw total scores for each paper [20]. The item-rest correlation for 
individual question items was calculated using Pearson’s correlation between candidates’ scores on 
the item with their total score on all other items combined. 
 
Results 
 
Candidate performance 
A total of 7,343 final-year students from 31 UK medical schools participated in PSA2016 and sat one 
of the four PSA ‘papers’ (A, B, C and D) in 200 PSA events held over four dates. Data from 254 
students from one school that experienced considerable technical difficulties (where all candidates 
were allowed an additional 30 minutes in which to complete the assessment) were excluded from 
analysis. The following data summarises the performance of the remaining 7,089 candidates. 
 
The mean raw scores (SD) for the four papers ranged from 80.0% (8.3%) on Paper A to 76.1% (8.8%) 
on Paper D with an overall pass rate of 95% (compared to 91% in PSA2015 and 94% in PSA2014) 
(Table 2).  
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The range in pass rates for the individual papers was from 97.2% (Paper A) to 92.6% (Paper D). The 
pass rate amongst the 286 students re-sitting the PSA was 80% meaning that less than one percent 
of all UK students failed to pass the PSA by the end of the academic year. 
 
Reasonable adjustment in the form of allocation of extra time was provided to 693 candidates 
(9.8%). The first-sitting pass rate amongst students with extra time was 94%, compared to 95% 
among students without extra time (chi-squared=2.31, p=0.128). The mean (SD) calibrated score 
amongst students with extra time was 70.5% (11.8%), compared with 71.5% (11.3%) for those 
without extra time (t=2.20, p<0.001). 
 
When the individual sections of the PSA were considered separately, candidates appeared to do 
particularly well on the adverse drug reactions items (median section score on each paper 88%) and 
less well on the data interpretation items (median section score on each paper 67%) when 
compared to the overall paper (median scores 77 to 81%). A potential reason for the relatively poor 
performance on the latter section (which was also noted in PSA2015) is that data interpretation 
items are presented as the last section of the assessment and some candidates may be running out 
of time when these items are attempted (although questions can be attempted in any order). 
 
The 32 anchor items were distributed such that eight items were used for each combination of three 
papers. The mean percentage scores achieved by candidates across the eight repeated items in each 
set of papers were ABC (74.7 to 76.7%), ABD (76.9 to 78.2%), ACD (76.3 to 77.1%) and BCD (81.5 to 
82.1%) suggesting that there were only relatively small differences in performance of the cohorts 
attempting each paper.  
 
Some items have been used in two or three of the assessment diets run over the last four years 
(2013 to 2016). For the 16 items used in 2013 and 2016 the total absolute improvement in mean 
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item score was 11.7 percentage points. For the 40 items used in 2014 and 2016 the improvement 
was 1.1 percentage points and for the 78 items used in 2015 and 2016 it was 2.6 percentage points. 
 
Table 2 here. Candidate performance in PSA2016. 
 
Internal consistency 
The mean Cronbach’s alpha across the four papers was 0.75 (range 0.74 to 0.77) and the standard 
error of measurement was 4.19% (range 4.17 to 4.24%) (Table 2). The Cronbach’s alpha was almost 
identical to the 0.76 achieved in PSA2015 and above the 0.70 achieved in PSA2014. Using classical 
test theory 52% of items showed good discrimination, with an item-rest correlation greater than 0.2 
while 9% had an item-rest correlation less than 0.1. 
 
Performance by medical school 
The number of students taking the PSA at each school ranged from 47 to 430. Comparison of the 
performance of schools that took different papers was facilitated by calibrating the raw scores so 
that the pass mark was considered to be 50% for each. The mean calibrated scores across schools 
ranged from 63.2% to 78.2% (Figure 3). The result of a one-way ANOVA comparing mean student 
scores was F29,7059 = 32.6, p<0.001, indicating statistically significant differences in performance 
between schools.   
 
There was a strong positive correlation between the mean medical school scores recorded in 
PSA2015 and PSA2016 (Figure 4). The Pearson’s correlation coefficient for 2015 to 2016 was 0.79 
(95% CI 0.61 to 0.90; p<0.01). Mean scores improved between 2015 and 2016 at all but two schools. 
The variability across schools did reduce slightly, with standard deviations of mean scores 
(coefficients of variation) of 4.11% (0.061) in 2015 and 3.84% (0.054) in 2016. 
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Figure 3. Performance by medical school. 
Figure 4. Mean calibrated score by medical school in 2015 and 2016. 
 
 
Discussion 
Although medical schools and NHS hospitals had previously developed local prescribing assessments, 
there has never been a widely accepted measure of prescribing performance in medical education. 
Our intention was to develop a reliable and valid national prescribing assessment that might serve to 
enable medical students (and their medical schools) to demonstrate that they had achieved a basic 
standard of prescribing competence by the time of graduation. In addition, we hoped that the PSA 
might increase the visibility of prescribing in the curriculum, promote better training experiences, 
and provide some feedback about the impact of varying education strategies. This might, in turn, 
raise and unify prescribing standards and ultimately contribute to enhanced quality and safety of 
patient care. 
 
The PSA is the first national online prescribing assessment for final-year medical students. Since its 
original conception in 2010 it has become an annual part of the assessment cycle in all UK medical 
schools and is supported by a dedicated editorial team, a national panel of authors drawn from 
academia and the NHS, an Assessment Board responsible for a multi-stage quality assurance 
process, a Standard-Setting Sub-Group and a technical team responsible for maintaining and 
improving the online delivery system. The key points from this report of PSA2016 are that: (i) the 
overall performance of the candidates was good, (ii) there is some evidence that performance is 
improving, (iii) the reliability of the assessment is improving, and (iv) there is significant variation in 
the performance of students from different medical schools. 
 
Candidate performance 
The vast majority of final-year students were able to pass the PSA, meeting the standard of 
competence pre-defined by the Angoff-derived pass mark, and most of those who failed were able 
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to pass the PSA after a period of revision and remediation. The pass rate of 95% represented an 
improvement on previous years (compared to 91% in PSA2015 and 94% in PSA2014), which might 
represent a progressive improvement in performance. However, there may be other relevant 
factors. It is possible that the 2016 papers were easier relative to pass mark even though the 
standard-setters followed the same process and definitions. The announcement by the Foundation 
Programme that all entrants would be expected to have taken the PSA (and pass it by the end of 
their first year of training at the latest) undoubtedly raised the stakes for the students and might 
have increased the overall motivation of the candidates. This change would be particularly relevant 
for the majority of medical schools where taking the PSA was previously used as a formative 
assessment. There was also more support available for candidates than in previous years with four 
practice papers and 12 online videos describing the process and structure of the PSA. Some of the 
PSA2016 cohort also had experience of local ‘mock’ PSA events during their penultimate year of 
study in 2015. Anecdotal reports indicate that some medical schools had developed additional 
learning sessions focused on prescribing in an effort to prepare their students for the PSA. The 
better performance of candidates on items repeated over the years 2013 to 2016 and the slightly 
reduced variability in performance between medical schools also supports the belief that there is a 
genuine improvement in performance. 
 
Although the performance of the candidates is generally good, and seems to be improving, we hope 
that further improvements might be achieved. Part of that process will involve identifying some of 
the common mistakes and misunderstandings demonstrated by candidates and providing detailed 
feedback to medical schools. This should support the improvement of teaching and learning of 
prescribing amongst future cohorts. A final point to make is that the Angoff standard-setting process 
used to define competence remains a subjective and imprecise prediction, even if carefully executed 
[21]. It is dependent on the interpretation of the definition of the ‘just passing’ candidate by each of 
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the PSA standard-setters and how relevant the definition is to safe clinical practice and the risk of 
error. This uncertainty requires further exploration. 
 
Reliability 
The position of the PSA as a progressively high-stakes assessment of safe practice increases the focus 
on its reliability. The analysis of internal consistency showed that the mean Cronbach’s alpha was 
0.75, which was similar to PSA2015 (0.76) and higher than PSA2014 (0.70). Although this remains 
below the 0.8 that some have suggested to be the minimum acceptable reliability for a high stakes 
test [22], it compares well with other multi-domain assessments limited to only two hours duration 
[23]. Indeed, others recommend acceptance of a lower alpha value (0.70) to ensure that the 
reliability of an assessment does not come at the expense of validity (i.e. high reliability would be 
achieved by assessing a narrow range of skills and areas of knowledge rather than sampling from the 
entire skill set required for safe prescribing) [24]. The Spearman-Brown formula predicts that the 
number of items in each section of the PSA would need to be increased by around 25% to achieve a 
reliability of 0.8, a change that might threaten the acceptability of the assessment. While we hope 
that the current reliability estimates will maintain support for the process, the PSA aims to identify 
and preserve the most discriminating question items, reject those that perform less well and provide 
constructive feedback to our item authors. 
 
Medical school variation 
There was a significant variation in the performance of final-year students studying in different 
medical schools and the performance in 2015 and 2016 was strongly correlated, implying that this is 
a real and consistent effect. There are a number of possible reasons for this variation. It might 
represent a genuine variation in the knowledge, skills and judgement that are the intended focus of 
the assessment. Previous reviews have suggested that there are variations in undergraduate 
training, visibility, emphasis and assessments in clinical pharmacology and prescribing [13]. These 
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variations were one of the reasons why the Safe Prescribing Working Group previously 
recommended the need for the development of a clear description of relevant learning outcomes 
[15,25,26], and access to national eLearning support materials [27]. The variation may also represent 
more general differences in the aptitudes of the cohorts such as their ability to perform in high-
stakes time-pressured assessments. A similar inter-school variation has been noted in other 
assessments such as subsequent performance in specific postgraduate examinations [28]. There may 
also be more subtle factors at play such as the timing of the assessments in relation to the local 
undergraduate curriculum, involvement of local teachers in the PSA process and the general 
enthusiasm and support for national assessments in general or the PSA in particular. 
 
Important limitations 
There are some important inherent limitations in developing and implementing the PSA as a national 
prescribing assessment. Foremost is the lack of a demonstrable association between performance in 
its controlled environment and prescribing competence in the real world of clinical practice. This 
question must be addressed but poses significant difficulties, primarily because of the lack of an 
easily applied measure of real life performance, the inherent variability of case mix in clinical 
practice and numerous other factors that influence individual practice (e.g. workload, supervision). 
 
There are always potential technical risks in delivering live online assessments. Although major 
problems have been rare in our experience, network slowing can cause problems (e.g. slow page 
loading, slow item turnover, screen freezes) at peak times involving several thousand candidates. 
These problems severely affected one site involved in PSA2016 although online delivery from the 
‘cloud’ means that candidate answers are not lost, even when connections fail.  
 
A frequent concern expressed by the candidates is the timing of the assessment. Keystroke logs 
suggest that almost all candidates remain active throughout the two-hour duration of the 
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assessment. While some candidates feedback that ‘patient safety tasks should never be rushed’ the 
reality of clinical practice is that time is often limited by workload pressures. Furthermore, the PSA is 
an open-book assessment during which all candidates have access to the BNF. The BNF cannot 
answer all questions but provides a valuable back up to support the candidates’ knowledge. The 
time limit places a premium on being able to use the BNF efficiently but does not allow reliance on 
the reference source to override the requirement for basic knowledge and clinical judgement gained 
through clinical training. 
 
The pass mark is relatively low for a high-stakes assessment. This reflects the fact that those items 
with the best discrimination tend to have a facility mid-way between guessing and maximum 
[29,30]. This highlights the tension between having an easier assessment composed of ‘must-know’ 
items with high facility and one that can more reliably differentiate candidates at the pass-fail cut 
score. 
 
Future issues 
A standardised tool for assessing prescribing competence might be deployed more widely than 
undergraduate medical education. Most doctors prescribe frequently throughout their careers and, 
like doctors in their first year of clinical practice, often make errors [3–5]. Since optimal prescribing 
practice changes frequently, an assessment of prescribing would also be highly relevant to 
postgraduate training and revalidation. Indeed, it might be argued that prescribing should feature 
prominently as an identifiable component of any broad assessment of competence to practise 
medicine. This will be an important consideration for the General Medical Council in its consultation 
about the structure of the new Medical Licensing Examination (MLA) [31]. Although identifying 
prescribing so clearly might run contrary to the current focus on integrated learning and assessment, 
we believe that it deserves such prominence. Few activities are undertaken so frequently by doctors, 
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carry such immediate implications for patient health outcomes [32], have such clearly documented 
rates of error in modern healthcare [3–5], or carry such a clear training-practice deficit [12]. 
 
Prescribing rights have now been extended to other prescribing groups (e.g. nurse practitioners, 
pharmacists) [33]. In recognition of this broadened definition of a ‘prescriber’ a national prescribing 
competency framework has been developed that identifies the generic abilities that should be 
possessed by all prescribing professionals [34], many of which feature in the PSA. Some early pilot 
work has been started to explore the utility of the PSA amongst other professional groups [35].  
 
A final consideration is whether the PSA will contribute to improved prescribing outcomes. It is well 
recognised that assessments influence learner and institutional priorities [36]. In this way the PSA is 
undoubtedly increasing the visibility of medicines safety as an outcome for graduates. As 
anticipated, evidence of ‘teaching to the test’ is emerging, so it is critical that the PSA remains firmly 
relevant to clinical practice. The candidate feedback suggests that the assessment is relevant to their 
training needs and that the chance to get feedback on their performance is welcomed. We believe 
that this initiative is beginning to deliver graduates who are better prepared to face the challenges 
of prescribing and supervising the use of medicines in the NHS. However, that gain can only be part 
of a wider drive to improve patient outcomes, which will also include better supervision and team-
working, point of care decision support, improved prescribing systems and avoiding unsustainable 
individual workloads [3,4,14].  
 
The PSA has proved to be a powerful tool to emphasise the importance of prescribing and 
the principles of clinical pharmacology. It has served to enhance familiarity with the online 
BNF, the standard reference resource for UK prescribers, amongst medical students. While 
we would also wish to promote familiarity with standardised prescribing documentation, 
the PSA has been unable to achieve this because of the myriad of paper-based forms in 
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current use. However, the online PSA is well-placed to align its future prescribing interface 
with electronic prescribing systems that are being increasingly implemented in UK hospitals. 
 
Conclusion 
The PSA is now a major national collaboration involving all UK medical schools. The annual scale of 
the PSA process (academic, administrative and technical) is now considerable: around 8,500 
students from the UK and overseas, 17,000 candidate hours of assessment and over half a million 
patient safety-related questions posed and marked (including 70,000 prescriptions). The PSA is 
beginning to meet many of its initial objectives in providing a more reliable and consistent 
assessment of prescribing competence at graduation as well as stimulating increased visibility in this 
key part of undergraduate training. The future of the PSA must involve ongoing efforts to maximise 
its quality, reliability and external validity. 
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Figure 1. Standard structure of the Prescribing Safety Assessment. 
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Figure 2. Example PSA question item screens: Prescribing (green), Prescription Review (blue), 
Planning Management (red), Calculation Skills (grey). 
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Figure 3. Candidate performance by medical school. 
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Figure 4. Mean calibrated score by medical school in 2015 and 2016. 
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Section Description Marks Question items
1 Prescribing (PWS) 80 8 items of 10 marks each
2 Prescription Review (REV) 32 8 items of 4 marks each
3 Planning Management (MAN) 16 8 items of 2 marks each
4 Providing Information (COM) 12 6 items of 2 marks each
5 Calculation Skills (CAL) 16 8 items of 2 marks each
6 Adverse Drug Reactions (ADR) 16 8 items of 2 marks each
7 Drug Monitoring (TDM) 16 8 items of 2 marks each
8 Data Interpretation (DAT) 12 6 items of 2 marks each
 TOTAL MARKS 200  
 
Table 1. Allocation of question items and marks to each PSA section. 
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 Paper A Paper B Paper C Paper D
Angoff pass mark (%) 62.0 65.5 63.0 63.0
Candidates 1,914* 1,869 1,746 1,560
Medical schools 20 16 16 17
Pass rate (%) 97.2 94.0 95.8 92.6
RAW SCORES (%)     
Mean (SD) 80.0 (8.3) 79.8 (8.5) 78.3 (8.2) 76.1 (8.8)
Median (IQR)
81.0 
(75.0 to 86.0)
81.0 
(75.0 to 86.0)
79.0 
(73.5 to 84.5)
77.0 
(71.0 to 82.5)
Range 36.5 to 97.5 38.0 to 97.5 32.0 to 98.5 34.0 to 95.5
CALIBRATED SCORES (%)     
Mean (SD) 73.8 (10.7) 70.9 (11.6) 70.8 (10.7) 68.0 (11.2)
Median (IQR)
75.0 
(67.1 to 81.6)
72.5 
(63.8 to 79.7)
71.6 
(64.2 to 79.1)
68.9 
(60.8 to 76.4)
Range 29.4 to 96.7 29.0 to 96.4 25.4 to 98.0 27.0 to 93.9
Cronbach’s alpha 0.738 0.756 0.743 0.767
SEM (%) 4.24 4.17 4.13 4.23
 
Table 2. Candidate performance in PSA2016. * A further 254 candidates at one school sat Paper A 
but experienced significant technical difficulties and are not included in this analysis. Their pass rate 
(97.6%) was similar to the remainder of the candidates sitting Paper A.  
SD: Standard deviation, IQR: Inter-quartile range; SEM: Standard error of measurement 
